{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:26:55Z","timestamp":1793950015720,"version":"4.8.0"},"reference-count":42,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment and neuropsychiatric manifestations are common disabling non-motor symptoms that can negatively impact quality of life in Parkinson's disease. This review aimed to critically appraise and synthesize evidence on the prevalence, predictors, and emerging biomarkers of cognitive impairment and neuropsychiatric manifestations among patients with Parkinson's disease in Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review of studies reporting cognitive and neuropsychiatric outcomes among individuals with Parkinson's disease in African populations, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We used the Critical Appraisal Skills Program checklist to determine the quality of the included studies. The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to estimate the certainty of the evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 32 studies, including 3687 patients, were analyzed. The prevalence of cognitive impairment ranged from 21.6% to 92%. Depression was the most common neuropsychiatric symptom (up to 81.7%). Consistent predictors of cognitive impairment included older age, advanced disease, and greater motor severity\n                      <jats:bold>.<\/jats:bold>\n                      Importantly, APOE \u03b54 homozygosity was associated with a twofold increase in the risk of cognitive impairment, while findings on LRRK2 G2019S mutations were heterogeneous across populations. Additionally, hypocalcemia and retinal nerve fiber layer thinning were linked to worse cognitive outcomes. Functional neuroimaging studies revealed altered emotional processing, with enhanced activation of limbic and cortical networks in response to positive emotional stimuli.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Evidence from this review suggests that cognitive impairment and neuropsychiatric manifestations are common in African PD populations and may be associated with clinical, genetic, metabolic, and neurobiological factors, although the quality of the evidence is low. Larger, community-based, and longitudinal studies are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x261479269","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:30:21Z","timestamp":1786721421000},"page":"1501-1514","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, predictors, and emerging biomarkers for cognitive impairment and neuropsychiatric manifestations in Parkinson's disease in Africa: A systematic review"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-8516","authenticated-orcid":false,"given":"Mundih Noelar","family":"Njohjam","sequence":"first","affiliation":[{"name":"National University Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falonne Tiffany","family":"Niakam","sequence":"additional","affiliation":[{"name":"National University Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Olivier","family":"Ngoule","sequence":"additional","affiliation":[{"name":"University Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"e_1_3_3_2_2","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey ER","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, et al. The emerging evidence of the Parkinson pandemic. J Park Dis 2018; 8: S3\u2013S8. PubMed PMID: 30584159; PubMed Central PMCID: PMC6311367.","journal-title":"J Park Dis"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2401857"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01478-2"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0055-3"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crbeha.2021.100049"},{"key":"e_1_3_3_7_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J 2021 Mar 29; 372: n71. PubMed PMID: 33782057.","journal-title":"Br Med J"},{"key":"e_1_3_3_8_2","unstructured":"PubMed [Internet]. [cited 2026 May 29]. PubMed. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/."},{"key":"e_1_3_3_9_2","unstructured":"African Journals Online [Internet]. [cited 2026 May 29]. Available from: https:\/\/www.ajol.info\/index.php\/ajol."},{"key":"e_1_3_3_10_2","unstructured":"Sabinet African Journals [Internet]. 2026 [cited 2026 May 29]. Sabinet African Journals. Available from: https:\/\/journals.co.za\/."},{"key":"e_1_3_3_11_2","unstructured":"Cochrane reviews. Cochrane Library [Internet]. [cited 2026 May 29]. Available from: https:\/\/www.cochranelibrary.com\/?contentLanguage=enNational."},{"key":"e_1_3_3_12_2","unstructured":"Google Scholar [Internet]. [cited 2026 May 29]. Available from: https:\/\/scholar.google.com\/."},{"key":"e_1_3_3_13_2","unstructured":"ScienceDirect.com. Science health and medical journals full-text articles and books. [Internet]. [cited 2026 May 29]. Available from: https:\/\/www.sciencedirect.com\/."},{"key":"e_1_3_3_14_2","unstructured":"CASP - Critical Appraisal Skills Program [Internet]. [cited 2026 Mar 21]. CASP - Critical Appraisal Skills Program. Available from: https:\/\/casp-uk.net."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22087"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.4236\/wjns.2018.84037"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.247470"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-019-0097-4"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.2016.v106i6.10340"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.23276"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2015.11.006"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2018.07.009"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.10.009"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00411-x"},{"key":"e_1_3_3_25_2","first-page":"2412486","article-title":"LRRK2 G2019s mutation: prevalence and clinical features in Moroccans with Parkinson\u2019s disease","volume":"2017","author":"Bouhouche A","year":"2017","unstructured":"Bouhouche A, Tibar H, Ben El Haj R, et al. LRRK2 G2019s mutation: prevalence and clinical features in Moroccans with Parkinson\u2019s disease. Park Dis 2017; 2017: 2412486. PubMed PMID: 28465860; PubMed Central PMCID: PMC5390546.","journal-title":"Park Dis"},{"key":"e_1_3_3_26_2","first-page":"594","article-title":"Assessment of serum calcium level in relation to cognitive dysfunction in patients with Parkinson\u2019s disease","volume":"30","author":"Badawy AE","unstructured":"Badawy AE, Elmotaym AS, Ghonemy M, et al. Assessment of serum calcium level in relation to cognitive dysfunction in patients with Parkinson\u2019s disease. Zagazig Univ Med J 2024 Jun 11; 30: 594\u2013601.","journal-title":"Zagazig Univ Med J"},{"key":"e_1_3_3_27_2","unstructured":"AJNS \u2013 African Journal of Neurological Sciences. The clinical profile of idiopathic parkinson\u2019s disease in a South African hospital complex \u2013 the influence of ethnicity and gender [Internet]. [cited 2026 Mar 10]. Available from: https:\/\/ajns.paans.org\/the-clinical-profile-of-idiopathic-parkinsons-disease-in-a-south-african-hospital-complex-the-influence-of-ethnicity-and-gender\/."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.10.021"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27902"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/bs11050074"},{"key":"e_1_3_3_31_2","first-page":"110","article-title":"Neuropsychiatric symptoms in Parkinson\u2019s disease: beyond complications","volume":"7","author":"Kehagia AA","unstructured":"Kehagia AA. Neuropsychiatric symptoms in Parkinson\u2019s disease: beyond complications. Front Psychiatry 2016 Jun 23; 7: 110. PubMed PMID: 27445867.","journal-title":"Front Psychiatry"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.668559"},{"key":"e_1_3_3_33_2","first-page":"1787","article-title":"Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort","volume":"130","author":"Ch WG","unstructured":"Ch WG, F T, Ce B, et al. Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort. Brain J Neurol 2007 Jul; 130: 1787\u20131798. PubMed PMID: 17535834.","journal-title":"Brain J Neurol"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00280-3"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13"},{"key":"e_1_3_3_36_2","article-title":"APOE4, Blood neurodegenerative biomarkers, and cognitive decline in community-dwelling older adults","volume":"8","author":"Ng TKS","unstructured":"Ng TKS, Beck T, Boyle P, et al. APOE4, Blood neurodegenerative biomarkers, and cognitive decline in community-dwelling older adults. JAMA Netw Open 2025 May 7; 8: e258903.","journal-title":"JAMA Netw Open"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146940"},{"key":"e_1_3_3_38_2","doi-asserted-by":"crossref","unstructured":"Okubadejo NU Bower JH Rocca WA et al. Parkinson\u2019s disease in Africa: A systematic review of epidemiologic and genetic studies [Internet]. doi:10.1002\/mds.21153.","DOI":"10.1002\/mds.21153"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.11.025"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1578"},{"key":"e_1_3_3_41_2","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies","volume":"90","author":"Smith C","unstructured":"Smith C, Malek N, Grosset K, et al. Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 2019 Nov; 90: 1234\u20131243. PubMed PMID: 31444276.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.05.010"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610218001370"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261479269","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261479269","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261479269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:46:49Z","timestamp":1793947609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261479269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/1877718X261479269"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261479269","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}